KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UiPath (PATH) Cash & Equivalents: 2021-2025

Historic Cash & Equivalents for UiPath (PATH) over the last 5 years, with Oct 2025 value amounting to $743.7 million.

  • UiPath's Cash & Equivalents fell 3.87% to $743.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $743.7 million, marking a year-over-year decrease of 3.87%. This contributed to the annual value of $879.2 million for FY2025, which is 17.19% down from last year.
  • As of Q4 2025, UiPath's Cash & Equivalents stood at $743.7 million, which was up 18.30% from $628.6 million recorded in Q3 2025.
  • In the past 5 years, UiPath's Cash & Equivalents ranged from a high of $1.8 billion in Q3 2021 and a low of $357.7 million during Q1 2021.
  • Over the past 3 years, UiPath's median Cash & Equivalents value was $971.2 million (recorded in 2023), while the average stood at $973.7 million.
  • As far as peak fluctuations go, UiPath's Cash & Equivalents skyrocketed by 394.48% in 2022, and later plummeted by 38.89% in 2025.
  • Quarterly analysis of 5 years shows UiPath's Cash & Equivalents stood at $1.8 billion in 2021, then declined by 18.31% to $1.5 billion in 2022, then slumped by 30.88% to $1.0 billion in 2023, then decreased by 22.87% to $773.6 million in 2024, then decreased by 3.87% to $743.7 million in 2025.
  • Its Cash & Equivalents was $743.7 million in Q4 2025, compared to $628.6 million in Q3 2025 and $700.6 million in Q2 2025.